Testing a urine test to reduce the need for bladder scopes for invisible blood in urine
Part of Cancer, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study tests a new urine test called Cxbladder Triage Plus. The goal is to see if using this test can help some people avoid an unnecessary cystoscopy (a scope placed into the bladder) when they have invisible blood in their urine.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been sent to a doctor because of blood in your urine that can only be seen with a microscope or a dipstick test (invisible blood).
- You are between 19 and 88 years old.
- You can give a urine sample and are able to follow the study instructions.
- You understand English or Spanish (with an interpreter for Spanish speakers).
- You have never had bladder cancer or certain related cancers.
- You have not had a cystoscopy or hospital stay for visible blood in the past year.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at a simple urine test to see if it can help tell who might have bladder cancer when there is invisible blood in the urine. It is for people over 40 who have had this finding recently.
This study tests whether a special urine testing approach can better identify and sort risk in people (especially veterans) who were referred to urology for blood in the urine. It may help doctors decide who needs more urgent follow-up and which next steps to take.
This trial tests if we can safely skip a bladder camera test (cystoscopy) for people who have microscopic blood in their urine. If you meet certain criteria, you may not need the procedure.
This trial checks whether a new lab test on urine can help sort out which people with small amounts of blood in the urine (microscopic hematuria) might have bladder cancer. It may help doctors evaluate symptoms more accurately and decide who needs further testing.
This Phase 2 study tests whether urine tests can help monitor “non-muscle-invasive” bladder cancer without doing as many invasive bladder scopes (cystoscopies). If you qualify, you may be able to replace some scope visits with urine sample testing while still keeping close watch for cancer coming back.
This study collects urine samples to test UroAmp, a new genetic test that may help detect and monitor bladder cancer. It is for people with bladder cancer or blood in urine who want to help improve cancer detection.
Hear when a new Hematuria - Cause Not Known trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.